Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
what tier are glp-1 drugs The Impact of Receptor Agonists on Sedation Bristol Myers Squibb - packes:1 collection_pain
Bristol Myers Squibb - U.S. FDA Approves Bristol Myers Squibb's Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
95% CI 0.41–0.49)
collection_pain
packes:1
doi: 10.1016/S2213-8587(21)00002-4 24 GrootjenLNUylNEMvan BeijsterveldtIALPDamenLKerkhofGFHokken-KoelegaACS
US$ 27.48
US$ 23.67
US$ 29.38
US$ 22.16
